- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07851116
Tissue Sensor to Reduce the Need for Controlled Apnea During Retrograde Intrarenal Surgery (Tissue Sensor)
Retrograde intrarenal surgery is an established minimally invasive treatment for renal stones. During laser lithotripsy, respiratory motion causes the kidney, renal collecting system, and stone to move relative to the distal tip of the laser fiber. This can impair precise fiber positioning, reduce operative-field stability, and increase the risk of unintended laser exposure of the urothelium of the renal collecting system.
To reduce respiratory motion of the kidney, the surgeon may ask the anesthesiologist to temporarily pause mechanical ventilation. Controlled apnea can briefly stabilize the operative field; however, it requires interruption of ventilation and may cause oxygen desaturation, carbon dioxide accumulation, hemodynamic changes, and increased anesthetic burden.
Tissue Sensor is a technology that automatically terminates laser emission when contact between the distal tip of the laser fiber and tissue is detected. Tissue Sensor is expected to reduce the risk of unintended laser exposure of the renal collecting-system mucosa during respiratory motion of the kidney.
Greater surgeon confidence in the safety of laser activation may reduce the need to stabilize the kidney with controlled apnea. At the same time, brief automatic interruptions of laser emission may increase lithotripsy time and total operative time.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: Nikita Astakhov
- Telefoonnummer: +8 (968) 490-46-72
- E-mail: astakhov.nikita@inbox.ru
Studie Contact Back-up
- Naam: Vigen Malkhasyan, Doctor of Medical Sciences
- Telefoonnummer: +79096441688
- E-mail: botkinhospital@zdrav.mos.ru
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Age 18 years or older.
- A single renal stone.
- An indication for elective RIRS.
- Feasibility of performing the intervention with a flexible ureteroscope.
- Recommended stone diameter on CT: 7-15 mm.
- Stone located in a calyx, a group of calyces, or the renal pelvis.
- Feasibility of TFL use.
- General anesthesia with controlled mechanical ventilation.
- No active urinary tract infection.
- Ability to undergo low-dose non-contrast CT at 1 month.
- Signed written informed consent.
Exclusion Criteria:
- Multiple stones in the study kidney.
- Complete or partial staghorn stone.
- Ipsilateral ureteral stone.
- Renal or upper urinary tract anomaly that substantially alters the anatomy.
- Horseshoe, pelvic, or ectopic kidney.
- Stone within a calyceal diverticulum.
- Ureteral stricture.
- Previous reconstructive surgery involving the study kidney or ureter.
- Active infection, obstructive pyelonephritis, or urosepsis.
- Nephrostomy drainage.
- Pregnancy.
- Severe respiratory failure or a contraindication to apnea.
- Severe cardiovascular instability.
- Inability to undergo general anesthesia.
- Combined, bilateral, or percutaneous intervention.
- Suspected upper urinary tract tumor.
- Inability to comply with the study protocol.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Opdracht voor een enkele groep
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: patients with a single renal stone who are scheduled for elective retrograde intrarenal surger
RIRS will be performed using a thulium fiber laser with Tissue Sensor activated. All automatic system trigger events will be recorded and, whenever possible, synchronized with the procedure video recording. |
RIRS will be performed using the same TFL system with Tissue Sensor deactivated. Visually confirmed contacts between the activated laser fiber and the mucosa will be recorded from the procedure video. RIRS will be performed using a thulium fiber laser with Tissue Sensor activated. All automatic system trigger events will be recorded and, whenever possible, synchronized with the procedure video recording.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Tijdsspanne |
|---|---|
|
Proportion of patients requiring at least one episode of controlled intraoperative apnea during laser lithotripsy.
Tijdsspanne: intraoperative
|
intraoperative
|
Secundaire uitkomstmaten
Uitkomstmaat |
Tijdsspanne |
|---|---|
|
• number of apnea episodes;
Tijdsspanne: intraoperative
|
intraoperative
|
|
total apnea duration;
Tijdsspanne: intraoperative
|
intraoperative
|
|
mean number of apnea episodes per patient;
Tijdsspanne: intraoperative
|
intraoperative
|
|
maximum duration of a single apnea episode;
Tijdsspanne: intraoperative
|
intraoperative
|
|
minimum SpO2;
Tijdsspanne: intraoperative
|
intraoperative
|
|
incidence of desaturation;
Tijdsspanne: intraoperative
|
intraoperative
|
|
visible laser-induced mucosal
Tijdsspanne: intraoperative
|
intraoperative
|
Medewerkers en onderzoekers
Sponsor
Studie record data
Bestudeer belangrijke data
Studie start (Geschat)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Andere studie-ID-nummers
- MoscowBotkinHospital3
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .